Next Article in Journal
Lower-Limb Flexibility Profile in 142 Competitive Female Football Players: A Cross-Sectional Study
Next Article in Special Issue
Estimation of Cylinder Grasping Contraction Force of Forearm Muscle in Home-Based Rehabilitation Using a Stretch-Sensor Glove
Previous Article in Journal
RHLP-18T: A Radiation-Hardened 18T SRAM with Enhanced Read Stability and Low Power Consumption
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Evaluation of a Newly Developed Device for Resonance Disorders: A Clinical Pilot Study

1
Research Institute of Clinical Medicine of Jeonbuk National University—Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju 54907, Republic of Korea
2
Department of Speech-Language Therapy, The Graduate School, Jeonbuk National University, Jeonju 54907, Republic of Korea
3
Department of Physical Medicine and Rehabilitation, Jeonbuk National University, Jeonju 54907, Republic of Korea
*
Author to whom correspondence should be addressed.
Appl. Sci. 2025, 15(10), 5713; https://doi.org/10.3390/app15105713
Submission received: 21 March 2025 / Revised: 14 May 2025 / Accepted: 15 May 2025 / Published: 20 May 2025
(This article belongs to the Special Issue Applications of Emerging Biomedical Devices and Systems)

Abstract

This clinical pilot study aimed to assess the clinical effectiveness of a newly developed device, Smart NasoTM, for resonance disorders and compare its performance with that of the Nasometer II 6450. A group of 18 total participants (nine each in normal and hypernasality groups) were examined using the VIP inspection and K SNAP Test while wearing Nasometer II 6450 or Smart NasoTM, and the reliability of the new device and similarity of both devices were evaluated. When the newly developed Smart Naso™ and Nasometer II 6450 were applied to the hypernasality group, similarity was observed (Smart NasoTM: 0.776–0.989, Nasometer II: 0.922–0.996). In the test–retest reliability evaluation, both devices were found to be highly effective and reliable in the hypernasality group (Smart NasoTM: 0.948, Nasometer II: 0.953); the Smart NasoTM was found to be similarly effective and reliable for clinical applications. Smart Naso™ exhibited comparable effectiveness to that of Nasometer II 6450 and exhibits clinical utility for patients with hypernasality and those diagnosed with cleft lip and palate, cleft palate, and submucosal cleft palate.

1. Introduction

In speech production, the glottic tone originates in the lungs and is generated in the vocal tract through the vocal organ. This glottic tone resonates through selective amplification and filtration based on the characteristic shape of the vocal tract and is released through the oral and nasal cavities, which are the articulatory organs. When the velopharyngeal valve exhibits velopharyngeal incompetence owing to anatomical defects, neurological damage, or functional causes during speech sound generation, resonance disorders may occur [1,2].
Resonance disorders typically encompass the cleft lip and palate and the submucosal cleft palate, which are also associated with dental malocclusion, upper airway obstruction, and hearing impairment [3,4,5]. Kummer [4] categorized resonance disorders into hypernasality, hyponasality, mixed nasality, and cul-de-sac resonance. Hypernasality is characterized by nasalance that produces excessive nasal resonance during the production of glides, liquid sounds, and oral consonants. Notably, high nasalance is more pronounced in high vowels (i, ɯ, u) than in low vowels (e, a).
When evaluating nasalance in normal adults, it is essential to consider sex, age, and geographical dialect as well as segmental and suprasegmental factors and inspection word length. Consequently, establishing normal reference values presents considerable challenges [6]. A nasometer, which is non-invasive and exhibits the highest correlation with auditory perceptual investigation outcomes, is a widely used computer-based system [7] that quantitatively measures sound between the nasal and pharyngeal cavities [8,9,10]. The device captures oral and nasal consonants through a microphone, divides the nasal acoustic energy into the sum of the oral and nasal acoustic energy, multiplies this value by 100, and displays it as a percentage, thereby facilitating the assessment of nasal resonance for analyzing nasalance. Nasometers are utilized globally for nasalance research and inspection [11,12,13,14,15,16]. Despite the numerous advantages, the clinical application of nasometers is limited owing to the following factors: non-differentiation of headgear sizes for adults and children; risk of cutaneous irritation when tightened; cumbersome and heavy design resulting in discomfort during prolonged use; significant transportation requirements of all associated programs; and high costs owing to international import [17,18].
Recently, Smart Naso™ was developed for patients with resonance disorders to address the aforementioned limitations [17,19]. This study aimed to assess the clinical effectiveness of this device, verifying its efficacy and reliability compared to the existing device, Nasometer II 6450, by measuring the nasalance of patients with resonance disorders. We hypothesized that Smart Naso™ would be non-inferior to Nasometer II 6450 in terms of the reliability and similarity of nasalization measurements of participants in the normal and hypernasality groups.

2. Materials and Methods

2.1. Study Design

This study was approved by the Institutional Review Board (IRB) of Jeonbuk National University Hospital (IRB No.:2022-05-055, CRIS No: KCT0008727). The study cohort comprised nine patients in the normal group (mean age: 13.56 ± 5.88 years) and nine patients in the hypernasality group (mean age: 14.44 ± 7.00 years) who presented at the outpatient departments of Rehabilitation and Oral Maxillofacial Surgery at the Jeonbuk National University Hospital Dental Center at 20, Geonjiro Deokjin-gu, Jeonju-si, Jeollabuk-do from February 2023 to April 2023 (Table 1).
A randomized order table was created using a computer program to generate a series of random numbers. This table was used for screening through block random assignment: each measurement session for each participant was divided into blocks, and Smart Naso and Nasometer devices were assigned 1:1 using www.randomization.com.

2.2. Enrollment Procedures

(1) Prior to assessment, the therapist thoroughly disinfected two nasometers (Nasometer II 6450, KayPENTAX, Lincoln Park, NJ and Smart Naso™, Humanopia, Co., Ltd., Pohang, Republic of Korea) with ethanol. The therapist turned on the PC and calibrated the Nasometer II 6450 device using the associated program according to the manufacturer’s instructions. Additionally, the therapist activated the power of Smart Naso™, connected it to a laptop (LG Electronics Gram 15-inch, 15Z95N-GA56K) via Bluetooth, and subsequently checked Smart Naso™.
(2) On the day of the participant’s visit, the velopharyngeal insufficiency (VPI) screening test was performed to evaluate nasalance while conducting an auditory perceptual evaluation using the VPI articulation differential inspection scale (Table 1) [17].
The VPI articulation differential inspection scale ranged from 0 to 4 points (0 points: normal, 1 point: minimal, 2 points: mild, 3 points: moderate, and 4 points: severe). Patients scoring 0 points were placed in the normal group, and those scoring ≥1 point were placed in the hypernasality group.
(3) After the screening test, participant nasalance was measured using the newly developed Smart Naso™ or Nasometer II 6450 according to a randomized order table. Following a 5 min interval, nasalance was reassessed using Smart Naso™ or Nasometer II 6450, following the same procedure.
The inspection words were derived from the K SNAP Test, which was developed by the Dental Treatment Center at Jeonbuk National University Hospital through translation of the SNAP Test-R [5,20].

2.3. VPI Articulation Differential Inspection

To differentiate between the hypernasality and normal groups, this study conducted an auditory perceptual evaluation, specifically the VPI articulation differential inspection [21].
The evaluation sentences included 2-syllable words comprising mid and low vowels at the vowel level; 1-, 2-, and 3-syllable words consisting of stop sounds; 2- and 3-syllable words consisting of affricate sounds; 1- and 2-syllable words consisting of sibilant sounds; 3-syllable words consisting of lateral sounds; 2-syllable words consisting of glottal sounds; and 2-syllable words consisting of nasal consonants at the consonant level (Table 2).

2.4. K SNAP Test

In this investigation, the inspection word patterns utilized were based on the K SNAP Test (Table 3), which was developed for clinical use by the Department of Oral Maxillofacial Surgery at the Jeonbuk National University Hospital Dental Center based on the SNAP Test, a test for cleft palate and speech disorders published by Kay PENTAX in the United States. The inspection sentence patterns were as follows: at the vowel level, low vowel /a/ and high vowel /i/ are at the syllable repetition level; meaningless 2-syllable repetition consists of bilabial nasal, alveolar nasal, and velar nasal. Furthermore, the patterns at the sentence level were as follows: a simple sentence with 10 syllables (2 low vowels, 2 middle vowels, and 5 high vowels) for 1 person; a simple sentence with 11 syllables (2 middle vowels, 7 high vowels, and 2 diphthongs) for 2 persons; and a simple sentence with 12 syllables (2 low vowels, 4 middle vowels, 5 high vowels, and 1 diphthong) for 3 persons.

2.5. Device Preparation

Smart Naso™ was designed to enhance the ease and comfort of measuring nasalance by connecting to the application site (software program used by connecting to an Internet address) through Bluetooth pairing, utilizing a PC with Internet access without the need to install specific software [17].
The hardware comprises a speech input/output device designed to calculate nasalance by connecting to a PC application via Bluetooth and capturing nasal sound energy with a microphone. The helmet-shaped headgear is adjustable to accommodate various head sizes, and the philtrum separator features an adjustable wire that enables adjustment to fit the face size (Figure 1).

2.6. Statistical Analysis

After randomly testing and retesting the newly developed Smart Naso™ and the existing Nasometer II 6450 in any order on patients with a diagnosed cleft palate in the hypernasality group with the normal group as a control, the newly developed Smart Naso™ and the existing Nasometer II 6450 were tested and retested in the same way after a 5 min interval. The results were statistically analyzed to determine the effectiveness and reliability of the newly developed Smart Naso™ as a clinical nasometer compared to the existing Nasometer II 6450 [22] as follows:
  • Cosine similarity was employed to evaluate the effectiveness of both devices for nasalance measurements in the normal and hypernasality groups.
  • To examine the consistency of inspection results without measurement errors when Smart NasoTM and the Nasometer II 6450 were applied to measure and re-measure nasalance in the normal and hypernasality groups. The test–retest reliability of the devices was analyzed using the intraclass correlation coefficient (ICC).
ICC refers to the degree to which the scores allocated to the same subject are similar. The reliability judgment criteria range from 0 (not at all consistent) to 1 (perfectly consistent), with values closer to 1 indicating stronger reliability [23].
In this study, the ICC was categorized into four levels based on the 95% confidence interval: low (0.50 < ICC), moderate (0.50 ≦ ICC < 0.75), high (0.75 ≦ ICC < 0.90), and very high (0.90 ≦ ICC).
All statistical analyses were performed using SPSS 24.0 (IBM SPSS Statistics for Windows Version 24.0, Armonk, NY, USA: IBM Corp) with a statistical significance level of 0.05.

3. Results

3.1. Similarity Evaluation

To assess the effectiveness of the newly developed Smart Naso™ and existing Nasometer II 6450, we initially measured nasal sound and subsequently examined the consistency of the mean nasalance values of the normal and hypernasality groups using the cosine similarity technique.
Cosine similarity values range between 0 and 1, with values closer to 1 signifying higher similarity, whereas those closer to 0 indicate low similarity.
In the normal group, nasalance measurements of the two devices demonstrated similarity >90% for the sentence patterns /i/, /papi papi papi/, /mami mami mami/, /nani nani nani/, /aŋiŋ aŋiŋ aŋiŋ/, and /ʌmmanɯn remontɕusɯl mandɯrʌjo/. For the sentence patterns /phaphi phaphi phaphi/, /p’ap’i p’ap’i p’ap’i/, /phaiɛ pʌthʌrɯl parɯsio/, and /sukhiɰ tɯresɯrɯl posip˺s’io/, the devices exhibited > 80% similarity, whereas the sentence pattern of /a/ demonstrated > 70% similarity. In the hypernasality group, all sentence patterns exhibited >90% similarity (Table 4).

3.2. Reliability Evaluation

The test–retest reliability of nasalance measurement using the ICC was analyzed. In this study, the ICC was categorized as low (0.50 < ICC), moderate (0.50 ≦ ICC < 0.75), high (0.75 ≦ ICC < 0.90), and very high (0.90 ≦ ICC) based on the 95% confidence interval.

3.2.1. Evaluation of Test–Retest Reliability of Both Devices in the Normal Group

In the normal group, the test–retest reliability of Smart NasoTM for nasal sounds was very high (≥0.90) for the sentence patterns /p’ap’i p’ap’i p’ap’i/ and /ʌmmanɯn remontɕusɯl mandɯrʌjo/, while demonstrating high reliability (≥0.75) for the sentence patterns /a/, /i/, /papi papi papi/, /phaphi phaphi phaphi/, /mami mami mami/, /phaiɛ pʌthʌrɯl parɯsio/, and /sukhiɰ tɯresɯrɯl posip˺s’io/, and moderate reliability (≥0.50) for the sentence patterns /nani nani nani/ and /aŋiŋ aŋiŋ aŋiŋ/ (Table 5).
In the normal group, the test–retest reliability of the Nasometer II 6450 for nasal sound was very high (≥0.90) for the sentence pattern /mami mami mami/, while showing high reliability (≥0.75) for the sentence patterns /a/, /i/, /papi papi papi/, /nani nani nani/, /aŋiŋ aŋiŋ aŋiŋ/, /sukhiɰ tɯresɯrɯl posip˺s’io/, and /ʌmmanɯn remontɕusɯl mandɯrʌjo/, moderate reliability (≥0.50) for the sentence patterns /p’ap’i p’ap’i p’ap’i/ and /phaiɛ pʌthʌrɯl parɯsio/, and low reliability (<0.50) for the sentence pattern /phaphi phaphi phaphi/.

3.2.2. Evaluation of Test–Retest Reliability of Both Devices in the Hypernasality Group

In the hypernasality group, the test–retest reliability of Smart NasoTM for nasal sound was very high (0.90 or higher) in the sentence patterns of /a/, /i/, /papi papi papi/, /phaphi phaphi phaphi/, /mami mami mami/, /phaiɛ pʌthʌrɯl parɯsio/, /sukhiɰ tɯresɯrɯl posip˺s’io/, and /ʌmmanɯn remontɕusɯl mandɯrʌjo/ and high (0.75 or higher) in the sentence patterns of /p’ap’i p’ap’i p’ap’i/ of /i/, /nani nani nani/, and /aŋiŋ aŋiŋ aŋiŋ/.
The test–retest reliability of the Nasometer II 6450 in the same group was very high (≥0.90) for the sentence patterns /a/, /i/, /phaphi phaphi phaphi/, /p’ ap’i p’ap’i p’ap’i/, and /phaiɛ pʌthʌrɯl parɯsio/, while demonstrating high reliability (≥0.75) for the sentence patterns /papi papi papi/, /mami mami mami/, /nani nani nani/, /aŋiŋ aŋiŋ aŋiŋ/, and /sukhiɰ tɯresɯrɯl posip˺s’io/, and low reliability (<0.50) for the sentence pattern /ʌmmanɯn remontɕusɯl mandɯrʌjo/ (Table 6).

4. Discussion

When the newly developed Smart Naso™ and existing Nasometer II 6450 were used in the hypernasality group, more than 90% similarity was observed; when both devices were applied to the normal group, a high similarity of 70–80% was observed. In a comparison of the two devices in the two groups, Smart Naso™ and Nasometer II 6450 exhibited comparable similarity. However, the newly developed Smart Naso™ demonstrated more than 90% similarity in patients with resonance disorders, indicating its clinical effectiveness. This difference can be induced owing to the system of nasalance calculations between the two devices, given that variations in nasalance can occur in different experimental environments and conditions among individuals [10,14,23].
In the reliability evaluation, ICC was utilized to verify the test–retest reliability for nasalance. During this process, low (0.50 < ICC), moderate (0.50 ≦ ICC < 0.75), high (0.75 ≦ ICC < 0.90), and very high (0.90 ≦ ICC) categories were designated based on the 95% confidence interval. Smart Naso™ test–retest was conducted on the normal group to determine if consistent results were obtained for the same subject. The results revealed that the inspection words /nani nani nani/ and /aŋiŋ aŋiŋ aŋiŋ/ demonstrated a reliability of 0.594 and 0.615, respectively, indicating a moderate level of reliability, while exhibiting high reliability for the sentence patterns /a/, /i/, /papi papi papi/, /phaphi phaphi phaphi/, /p’ap’i p’ap’i p’ap’i/, /mami mami mami/, /phaiɛ pʌthʌrɯl parɯsio/, and /sukhiɰ tɯresɯrɯl posip˺s’io/ and very high reliability for the sentence patterns /mami mami mami/ and /ʌmmanɯn remontɕusɯrɯl mandɯrʌjo/.
The test–retest using the Smart Naso™ in the hypernasality group with the inspection words /p’ap’i p’ap’i p’ap’i/, /nani nani nani/, and /aŋiŋ aŋiŋ aŋiŋ/ demonstrated very high reliability of 0.889, 0.895, and 0.793, respectively, and maintained high reliability (≥90%) for the remaining inspection words.
In the test–retest using the Nasometer II 6450 on the normal group, we observed that the inspection words /a/, /i/, /papi papi papi/, /nani nani nani/, /aŋiŋ aŋiŋ aŋiŋ/, and /ʌmmanɯn remontɕusɯrɯl mandɯrʌjo/ demonstrated high reliability of 0.861, 0.896, 0.751, 0.751, and 0.858, respectively, while exhibiting moderate reliability of 0.597 for the inspection words /p’ap’i p’ap’i p’ap’i/ and 0.689 for /phaiɛ pʌthʌrɯl parɯsio/. Low reliability (0.019) was observed for the inspection word /phaphi phaphi phaphi/.
In the test–retest using the Nasometer II 6450 in the hypernasality group, the inspection word of /ʌmmanɯn remontɕusɯrɯl mandɯrʌjo/ demonstrated low reliability of 0.190, and the inspection words of /papi papi papi/, /mami mami mami/, /nani nani nani/, /aŋiŋ aŋiŋ aŋiŋ/, and /sukhiɰ tɯresɯrɯl posip˺s’io/ exhibited high reliability of 0.857, 0.886, 0.856, and 0.864, respectively, while the inspection words /a/, /i/, /phaphi phaphi phaphi/, /p’ap’i p’ap’i p’ap’i/, and /phaiɛ pʌthʌrɯl parɯsio/ exhibited very high reliability of 0.935, 0.953, 0.946, 0.962, and 0.951, respectively.
Consequently, the Nasometer II 6450 was shown to be highly effective and reliable for the hypernasality group, and Smart NasoTM was similarly determined to be highly effective and reliable for clinical use.
While nasometer evaluations are characterized by a high level of validity not replaceable by instrumental techniques, they remain reliant on human sense and memory, thus potentially introducing subjectivity for each evaluator and leading to inconsistent results [24]. The nasometer method was developed to supplement auditory perceptual evaluation, which may still present reliability issues. Although nasometer research has extensively reported that various factors, such as vowel type, speech intensity, pitch, and frequency analysis, could affect nasalance, many researchers have verified its reliability and validity in clinical studies and practice, resulting in its widespread use [11,12].
The nasometer revealed that a higher proportion of nasal sounds in the typical inspection words developed by Fletcher [25] correlated with a higher nasalance value. As demonstrated in this study, this device proved highly useful for patients in the hypernasality group, with hypernasality typically observed in conditions such as cleft lip and palate, submucosal cleft palate, and deafness. Smart Naso™ exhibited a reliability >0.7 for all inspection words, suggesting that this device also can be a clinically valid evaluation tool for patients with hypernasality with the existing Nasometer II 6450. Further clinical research is required regarding the factors affecting nasalance in order to measure nasalance with high reliability.
Although nasometers have been used extensively for measuring nasalance and speech therapy, the weight of the separator and its contact with the philtrum have been reported to limit the natural movement of the patient’s upper lip and place uncomfortable pressure on the philtrum. This limits their use in clinical settings because nasometers require bulky and inconvenient hardware [18]. In addition, it has been claimed that nasometers are inconvenient and unsuitable for home use [19].
Although it has been shown that the newly developed device has the potential to be used for clinical evaluation, the small sample size of this study limits the generalizability of its findings showing lower similarity in the normal group comparison. A systematic clinical study with the expanded sample should be performed to compare the performance of Smart Naso™ with Nasometer II 6450.

5. Conclusions

This study compared the similarity and reliability of the nasalance measurement device (Smart Naso™), which was recently developed to evaluate resonance disorders, with an existing product through clinical evaluation. The quantitative analysis of the Smart Naso™ and Nasometer II 6450 devices, as well as an analysis of their suitability and effectiveness, led to the conclusion that Smart Naso™ exhibits clinical utility for patients with hypernasality. Moreover, our findings show that this device can also be useful for patients diagnosed with cleft lip and palate, cleft palate, and submucosal cleft palate.

Author Contributions

Conceptualization, K.-S.H. and M.-H.K.; methodology, K.-S.H. and M.-H.K.; formal analysis, K.-S.H., M.-S.K. and M.-H.K.; funding acquisition, K.-S.H. and M.-H.K.; project administration, K.-S.H. and M.-H.K.; visualization, K.-S.H. and M.-S.K.; writing of the original draft, K.-S.H., M.-S.K. and M.-H.K.; writing—review and editing, K.-S.H. and M.-H.K.; approval of the final manuscript, K.-S.H. and M.-H.K. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare (grant number: HR22C1832, RS-2024-00335828), and the Bio&Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT) (No. RS-2023-00236157).

Institutional Review Board Statement

This study was approved by the Institutional Review Board of the Rehabilitation Center of Jeonbuk National University Hospital (IRB No.: 2022-05-055, CRIS No: KCT0008727).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study. Written informed consent has been obtained from the patients to publish this paper.

Data Availability Statement

All data generated or analyzed during this study are included in this published article.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Kummer, A.W. Speech and resonance disorders related to cleft palate and velopharyngeal dysfunction: A guide to evaluation and treatment. Perspect. Sch. Based Iss. 2014, 15, 57–74. [Google Scholar] [CrossRef]
  2. Kuehn, D.P.; Moller, K.T. Speech and Language Issues in the Cleft Palate Population: The State of the Art. Cleft Palate Craniofac. J. 2000, 37, 1–35. [Google Scholar] [CrossRef]
  3. Boone, D.R.; McFarlane, S.C.; Von Berg, S.L.; Zraick, R.I. The Voice and Voice Therapy; Pearson Education, Inc.: Hoboken, NJ, USA, 2005. [Google Scholar]
  4. Kummer, A.W.; Lee, L. Evaluation and treatment of resonance disorders. Lang. Speech Hear. Serv. Sch. 1996, 27, 271–281. [Google Scholar] [CrossRef]
  5. Kummer, A.W. The MacKay-Kummer SNAP Test-R: Simplified Nasometric Assessment Procedures; KayPentax: Lincoln Park, NJ, USA, 2005. [Google Scholar]
  6. Maeda, S.; Huffman, M.; Krakow, R. Phonetics and Phonology: Nasals, Nasalization and the Velum; Academic Press: Cambridge, MA, USA, 1993. [Google Scholar]
  7. Dalston, R.M.; Warren, D.W.; Dalston, E.T. Use of nasometry as a diagnostic tool for identifying patients with velopharyngeal impairment. Cleft Palate Craniofac. J. 1991, 28, 184–188, discussion 188. [Google Scholar] [CrossRef] [PubMed]
  8. Kummer, A. Cleft Palate and Craniofacial Anomalies: The Effects on Speech and Resonance; Cengage Learning: Boston, MA, USA, 2008. [Google Scholar]
  9. Watterson, T.; Lewis, K.; Brancamp, T. Comparison of Nasalance scores obtained with the Nasometer 6200 and the Nasometer II 6400. Cleft Palate Craniofac. J. 2005, 42, 574–579. [Google Scholar] [CrossRef] [PubMed]
  10. Bressmann, T. Comparison of nasalance scores obtained with the Nasometer, the NasalView, and the oroNasal System. Cleft Palate Craniofac. J. 2005, 42, 423–433. [Google Scholar] [CrossRef] [PubMed]
  11. Pannbacker, M.; Lass, N.J.; Scheuerle, J.F.; English, P.J. Survey of services and practices of cleft palate-craniofacial teams. Cleft Palate Craniofac. J. 1992, 29, 164–167. [Google Scholar] [CrossRef]
  12. Haapanen, M.L. Nasalance scores in normal Finnish speech. Folia Phoniatr. 1991, 43, 197–203. [Google Scholar] [CrossRef] [PubMed]
  13. Watterson, T.; McFarlane, S.C.; Wright, D.S. The relationship between nasalance and nasality in children with cleft palate. J. Commun. Disord. 1993, 26, 13–28. [Google Scholar] [CrossRef]
  14. Awan, S.N.; Virani, A. Nasometer 6200 versus Nasometer II 6400: Effect on measures of nasalance. Cleft Palate Craniofac. J. 2013, 50, 268–274. [Google Scholar] [CrossRef] [PubMed]
  15. Van Lierde, K.M.; Van Borsel, J.; Cardinael, A.; Reeckmans, S.; Bonte, K. The impact of vocal intensity and pitch modulation on nasalance scores: A pilot study. Folia Phoniatr. Logop. 2011, 63, 21–26. [Google Scholar] [CrossRef] [PubMed]
  16. Mayo, R.; Floyd, L.A.; Warren, D.W.; Dalston, R.M.; Mayo, C.M. Nasalance and nasal area values: Cross-racial study. Cleft Palate Craniofac. J. 1996, 33, 143–149. [Google Scholar] [CrossRef] [PubMed]
  17. Yang, X.; Pratama, G.B.; Choi, Y.; You, H.; Tâm, N.P.M.; Kim, G.W.; Jo, Y.J.; Ko, M.H. Measurement of nasalance scores without touching the philtrum for better comfort during speech assessment and therapy: A preliminary study. Cleft Palate Craniofac. J. 2021, 58, 446–454. [Google Scholar] [CrossRef] [PubMed]
  18. Heller Murray, E.S.H.; Mendoza, J.O.; Gill, S.V.; Perkell, J.S.; Stepp, C.E. Effects of biofeedback on control and generalization of nasalization in typical speakers. J. Speech Lang. Hear. Res. 2016, 59, 1025–1034. [Google Scholar] [CrossRef] [PubMed]
  19. Cler, G.J.; Mittelman, T.; Braden, M.N.; Woodnorth, G.H.; Stepp, C.E. Video game rehabilitation of velopharyngeal dysfunction: A case series. J. Speech Lang. Hear. Res. 2017, 60, 1800–1809. [Google Scholar] [CrossRef] [PubMed]
  20. Pae, S.; Yoon, H.; Seol, A.; Gilkerson, J. The validity and reliability of the Korean version of the developmental snapshot. Commun. Sci. Disord. 2015, 20, 355–363. [Google Scholar] [CrossRef]
  21. Shin, H.K.; Leem, D.H.; Whang, S.J.; Kim, D.C.; Kin, H.G. Assessment and treatment of the cleft palate speech disorder by use of the nasometer. Korean J. Cleft Lip Palate 2008, 11, 1–12. [Google Scholar]
  22. Elemetrics, K. Nasometer II Model 6400 Installation, Operations, and Maintenance Manual; Kay Elemetrics: Lincoln Park, NJ, USA, 2003. [Google Scholar]
  23. Bressmann, T.; Klaiman, P.; Fischbach, S. Same noses, different nasalance scores: Data from normal subjects and cleft palate speakers for three systems for nasalance analysis. Clin. Linguist. Phon. 2006, 20, 163–170. [Google Scholar] [CrossRef] [PubMed]
  24. Ha, S. The Cleft Audit Protocol for Speech–Augmented-Korean Modification: Reliability Test. Commun. Sci. Disord. 2018, 23, 703–712. [Google Scholar] [CrossRef]
  25. Fletcher, S.G.; Adams, L.E.; McCutcheon, M.J. Cleft palate speech assessment through oral-nasal acoustic measures. In Communicative Disorders Related to Cleft Lip and Palate; Bzoch, K.R., Ed.; Little, Brown: Boston, MA, USA, 1989; pp. 246–257. [Google Scholar]
Figure 1. Smart Naso™ Device: (a) components of Smart Naso™; (b) description of a test.
Figure 1. Smart Naso™ Device: (a) components of Smart Naso™; (b) description of a test.
Applsci 15 05713 g001
Table 1. Participant characteristics.
Table 1. Participant characteristics.
Normal Group (n = 9)Hypernasality Group (n = 9)
Age, years13.56 (±5.88)14.44 (±7.00)
Sex (male/female)2:74:5
Table 2. Example of VPI articulation differential inspection sheet.
Table 2. Example of VPI articulation differential inspection sheet.
Inspection LevelsInspection
WordVowelsMiddle vowel‘Cucumber’ /o i/
Low vowel‘Crocodile’ /ɑ ɡ ʌ/
ConsonantsStop sound‘Frog’ /k ɛ ɡ u ɾ i/
‘Elephant’ /kh o k* i ɾ i/
‘Magpie’ /k* ɑ tɕh i/
‘Cabbage’ /p ɛ tɕh u/
‘Grape’ /ph o d o/
‘Horn’ /p* u l/
‘Pig’ /t wɛ dʑ i/
‘Ostrich’ /th ɑ dʑ o/
‘Strawberry’ /t* ɑ l ɡ i/
Affricate sound‘Swallow’ /tɕ ɛ b I/
‘Toothbrush’ /tɕh i t s* o l/
‘Mismatch’ /tɕ* ɑ k tɕ* ɑ ɡ i/
Sibilant sound‘Apple’ /s ɑ ɡ wa/
‘Clock’ /s i ɡ jɛ/
‘Rice’ /s* ɑ l/
Lateral sound‘Slipper’ /s ɯ l l i ph ʌ/
Glottal sound‘Pumpkin’ /h o b ɑ k/
Nasal consonants‘Garlic’ /m ɑ n ɯ l/
‘Butterfly’ /n ɑ b i/
‘Peacock’ /k o ŋ dʑ ɑ k/
Table 3. K SNAP Test sentences.
Table 3. K SNAP Test sentences.
Inspection LevelsArticulatory FormEvaluation ItemsComposition
VowelMonophthongA, /a/
I, /i/
Low vowel, /a/
High vowel, /i/
Syllable repetitionNasal soundBilabial nasalMommy, /mami/Low vowel, /a/
High vowel, /i/
6 syllables for each
(2 syllables, 3 repetitions)
Alveolar nasalNani /nani/
Velar nasalAnging /aŋiŋ/.
Low vowelMiddle vowelHigh vowelDiphthongs
Simple sentences1. Spread butter on the pie: /phaiɛ pʌthʌrɯl parɯs’io/225-
2. Look at Sook-hee’s dress: /sukhiɰ dɯrɛsɯl posip˺-272
3. My mom makes lemon juice: /ʌmmanɯn remontɕusɯrɯl mandɯrʌjo/2451
Table 4. Similarity of measured nasalance values by both devices in normal and hypernasality groups.
Table 4. Similarity of measured nasalance values by both devices in normal and hypernasality groups.
Similarity of Nasalance Values by Both Devices in the Normal GroupSimilarity of Nasalance Values by Both Devices in the Hypernasality Group
Sentence PatternSmart Naso™
Nasalance Value
Nasometer II 6450
Nasalance Value
SimilaritySmart Naso™
Nasalance Value
Nasometer II 6450
Nasalance Value
Similarity
/a/39.67 ± 13.7331.67 ± 24.780.77629.78 ± 9.7723.44 ± 9.580.922
/i/47.89 ± 23.0137.22 ± 21.620.94249.78 ± 20.8648.56 ± 24.490.958
/papi papi papi/35.11 ± 14.5321 ± 11.730.91535.67 ± 17.4425.67 ± 12.300.996
/phaphi phaphi phaphi/25.11 ± 8.0518.44 ± 11.700.87232.00 ± 20.3522.00 ± 14.290.988
/p’ap’i p’ap’i p’ap’i/33.22 ± 10.4118.89 ± 12.120.86836.78 ± 24.3622.67 ± 13.340.958
/mami mami mami/72.56 ± 9.4666 ± 12.70.98360.22 ± 8.9159.56 ± 6.670.982
/nani nani nani/71.22 ± 10.5667.33 ± 9.950.98263.11 ± 8.6560.44 ± 7.160.983
/aŋiŋ aŋiŋ aŋiŋ/79.86 ± 11.0276.33 ± 9.170.98968.56 ± 13.4873.33 ± 6.180.984
/phaiɛ pʌthʌrɯl parɯsio/25.78 ± 6.8217.56 ± 9.550.88930.33 ± 13.4022.67 ± 10.390.958
/sukhiɰ tɯresɯrɯl posip˺s’io/19.67 ± 6.9316.67 ± 10.460.84825.11 ± 11.9021.89 ± 14.130.963
/ʌmmanɯn remontɕusɯl mandɯrʌjo/54.22 ± 7.1249.56 ± 10.990.97449.44 ± 12.4741.44 ± 13.640.982
Table 5. Evaluation of the Smart Naso™ test–retest reliability in the normal group.
Table 5. Evaluation of the Smart Naso™ test–retest reliability in the normal group.
Test–Retest Reliability in the Normal Group
Sentence PatternReliability of Smart Naso™ Results Reliability of Nasometer II 6450 Results
Session 1Session 2ICC
(2,1)
Session 1Session 2ICC
(2,1)
/a/39.67
±13.73
37.44
±10.45
0.85931.67
±24.78
23.78
±16.87
0.861
/i/47.89
±23.01
38.22
±19.89
0.81037.22
±21.62
31.00
±20.96
0.896
/papi papi papi/35.11
±14.53
28.44
±8.56
0.78021.00
±11.73
23.11
±16.97
0.751
/phaphi phaphi phaphi/25.11
±8.05
22.67
±11.40
0.85818.44
±11.70
15.67
±12.43
0.019
/p’ap’i p’ap’i p’ap’i/33.22
±10.41
27.33
±8.50
0.92918.89
±12.12
12.56
±4.77
0.597
/mami mami mami/72.56
±9.46
66.89
±8.45
0.76566.00
±12.70
60.56
±10.42
0.910
/nani nani nani/71.23
±10.66
68.22
±9.09
0.59467.33
±9.95
64.44
±8.76
0.751
/aŋiŋ aŋiŋ aŋiŋ/79.89
±11.02
76.89
±10.53
0.61576.33
±9.17
75.00
±8.51
0.858
/phaiɛ pʌthʌrɯl parɯsio/25.78
±6.82
23.89
±8.75
0.83217.56
±9.55
12.22
±7.03
0.689
/sukhiɰ tɯresɯrɯl posip˺s’io/19.67
±6.96
17.44
±4.30
0.86316.67
±10.46
12.00
±5.20
0.760
/ʌmmanɯn remontɕusɯl mandɯrʌjo/54.22
±7.12
50.11
±7.85
0.92049.56
±10.99
43.22
±7.03
0.802
Table 6. Evaluation of the Smart Naso™ test–retest reliability in the hypernasality group.
Table 6. Evaluation of the Smart Naso™ test–retest reliability in the hypernasality group.
Test–Retest Reliability in the Hypernasality Group
Sentence PatternReliability of Smart Naso™ ResultsReliability of Nasometer II 6450 Results
Session 1Session 2ICC
(2,1)
Session 1Session 2ICC
(2,1)
/a/29.78
±9.77
29.11
±10.78
0.94824.78
±10.89
23.44
±9.58
0.935
/i/49.78
±20.56
51.33
±23.30
0.94845.67
±28.24
48.56
±24.49
0.953
/papi papi papi/35.67
±17.44
35.33
±15.28
0.98824.78
±13.74
25.67
±12.30
0.857
/phaphi phaphi phaphi/32.00
±20.35
30.44
±19.38
0.97720.89
±13.23
22.00
±14.29
0.946
/p’ap’i p’ap’i p’ap’i/36.78
±24.36
35.56
±19.35
0.88922.78
±11.85
22.67
±13.34
0.962
/mami mami mami/60.22
±8.91
59.78
±9.52
0.90258.89
±9.53
59.56
±6.67
0.886
/nani nani nani/63.11
±8.65
62.33
±11.99
0.89557.89
±8.67
60.44
±7.16
0.836
/aŋiŋ aŋiŋ aŋiŋ/68.56
±13.48
70.00
±9.89
0.79369.89
±9.60
73.33
±6.18
0.856
/phaiɛ pʌthʌrɯl parɯsio/30.33
±13.40
31.56
±12.97
0.97622.89
±10.01
22.67
±10.39
0.951
/sukhiɰ tɯresɯrɯl posip˺s’io/25.11
±11.90
27.56
±11.38
0.95824.33
±10.72
21.89
±14.13
0.864
/ʌmmanɯn remontɕusɯl mandɯrʌjo/49.44
±12.47
51.11
±8.43
0.93244.33
±7.81
41.44
±13.64
0.190
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Han, K.-S.; Kang, M.-S.; Ko, M.-H. Evaluation of a Newly Developed Device for Resonance Disorders: A Clinical Pilot Study. Appl. Sci. 2025, 15, 5713. https://doi.org/10.3390/app15105713

AMA Style

Han K-S, Kang M-S, Ko M-H. Evaluation of a Newly Developed Device for Resonance Disorders: A Clinical Pilot Study. Applied Sciences. 2025; 15(10):5713. https://doi.org/10.3390/app15105713

Chicago/Turabian Style

Han, Kap-Soo, Min-Seo Kang, and Myoung-Hwan Ko. 2025. "Evaluation of a Newly Developed Device for Resonance Disorders: A Clinical Pilot Study" Applied Sciences 15, no. 10: 5713. https://doi.org/10.3390/app15105713

APA Style

Han, K.-S., Kang, M.-S., & Ko, M.-H. (2025). Evaluation of a Newly Developed Device for Resonance Disorders: A Clinical Pilot Study. Applied Sciences, 15(10), 5713. https://doi.org/10.3390/app15105713

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop